Caribou Biosciences, Inc. (CRBU) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Caribou Biosciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.00x | -0.96x | -4.14x | -3.84x | -13.59x | -13.16x |
| P/B Ratio | 1.22x | 0.57x | 1.15x | 1.27x | 2.34x | -19.26x |
| P/S Ratio | 13.31x | 14.37x | 12.27x | 27.57x | 94.75x | 36.52x |
| Profitability | ||||||
| Gross Margin | 67.3% | 60.7% | 89.8% | 73.7% | 89.7% | -178.5% |
| Operating Margin | -1220.5% | -1667.2% | -336.6% | -768.2% | -697.8% | -292.2% |
| Net Margin | -1327.4% | -1491.9% | -296.1% | -717.8% | -697.3% | -277.6% |
| EBITDA Margin | -1187.8% | -1627.9% | -326.4% | -691.0% | -683.6% | -284.8% |
| Liquidity | ||||||
| Current Ratio | 5.71x | 7.16x | 11.97x | 9.25x | 15.15x | 1.96x |
| Quick Ratio | 5.71x | 7.16x | 11.97x | 9.25x | 15.15x | 1.96x |
| Leverage | ||||||
| Debt/Equity | 0.22x | 0.10x | 0.07x | 0.09x | 0.00x | -0.07x |
YoY = year-over-year change. Source: FMP..